VP, Head of Pharmacoepidemiology
Regeneron
Tarrytown, United States
Rachel Sobel, DrPH, FISPE serves as Executive Director and Head, Pharmacoepidemiology within Global Patient Safety at Regeneron Pharmaceuticals in Tarrytown, NY. She leads a team of epidemiologists and analysts who generate RWE in support of safety and other strategies across development. She is an epidemiologist with more than 23 years in epidemiology strategy for pharmaceutical products in a wide variety of therapeutic areas, including autoimmune, rare, and pediatric diseases.
Disclosure information not submitted.
Tuesday, August 27, 2024
1:00 PM – 1:15 PM CEST
Risk of Uveitis Following COVID-19 Diagnosis
Tuesday, August 27, 2024
2:15 PM – 2:30 PM CEST
Tuesday, August 27, 2024
1:45 PM – 2:00 PM CEST